AOD-9604 is an hGH 177-191 fragment studied for lipid metabolism, fat oxidation, and cartilage models.
Pre-loaded with a typical AOD-9604 vial. Change any value to match what you actually have.
What published research and laboratory protocols actually document for AOD-9604. Where a compound has no single microgram figure, we say so rather than inventing one.
| Reported amount | Frequency | Route | Where this figure comes from |
|---|---|---|---|
| 250 mcg | weekly in animal study protocol | intra-articular | Rabbit osteoarthritis model with intra-articular AOD9604 Animal model reference only. |
| 250 mcg – 500 mcg | daily in animal protocols | intraperitoneal or oral in preclinical studies | Obese rodent metabolic studies using AOD9604 Preclinical reference values; not human-use guidance. |
People searching this page also look for: aod 9604 peptide dosage, aod 9604 peptide dosage chart, aod9604 peptide dosage, aod9604 peptide dosage chart, aod 9604 peptide dosage for beginners, aod-9604 peptide dosage, aod-9604 peptide dosage chart, aod 9604 peptide dosage pdf female.
AOD-9604 is a synthetic analog of the C-terminal lipolytic region of human growth hormone, commonly described as hGH fragment 177-191 with an added tyrosine in some analytical contexts. Research has examined lipid metabolism, beta-adrenergic pathway interactions, fat oxidation, and body-weight effects in animal models. It has also appeared in analytical anti-doping and identification literature.
Despite the name, AOD-9604 is not growth hormone and does not share the full endocrine profile of intact hGH. Human development history exists, but much of the accessible mechanistic literature is preclinical. Research-grade AOD-9604 is Research Use Only and not for human consumption.
AOD-9604 is studied as a peptide fragment linked to hGH's lipolytic domain, with preclinical work examining lipolysis, fat oxidation, energy expenditure, and beta-adrenergic pathway relationships. Animal data suggest effects are not simply mediated through the full growth hormone receptor profile. Some studies report changes in beta3-adrenergic receptor expression or lipid-handling markers, while analytical papers focus on detection and metabolism.
lipid metabolism · fat oxidation models · hGH fragment pharmacology · anti-doping analysis · cartilage research
AOD-9604 is studied by metabolic researchers, endocrinology pharmacologists, anti-doping laboratories, and musculoskeletal model researchers. Reviewers usually separate preclinical mechanism papers from clinical-development claims and gray-market use.
Lyophilized AOD-9604 is commonly stored cold, dry, and protected from light; reconstituted research solutions are generally refrigerated and used promptly.
AOD-9604 is often discussed beside metabolic peptides, GLP-1 compounds, or GH secretagogues, but mechanisms and evidence levels differ sharply. Research designs should avoid stacking endocrine and incretin variables unless the study is built to separate appetite, lipolysis, glucose, and body-composition endpoints.
The questions people actually search for, answered plainly.
Published AOD-9604 ranges are largely preclinical or trial-context specific. They should be presented as study exposure values, not dosing advice.
Research examples often use 1-2 mL for small vials. Reconstitution volume only determines concentration for calculations.
Daily values found online often mix animal studies, old development programs, and marketing claims. Literature-based content should identify the source context.
A chart should separate animal mg or mcg exposures, route, species, and vial concentration math. It should not imply a human protocol.
Animal metabolic studies often evaluate outcomes over days to weeks. Analytical detection work uses much shorter in vitro windows.
A practical human half-life is not firmly established in widely used literature. Detection and metabolism studies are more reliable references.
It can be studied with other metabolic variables, but stacking can hide whether results come from appetite, lipolysis, endocrine, or activity changes.
Primary literature on AOD-9604. Open access where available.
Every citation above was programmatically checked against the NCBI PubMed database. Titles shown are the official indexed titles, not paraphrases.
Our support assistant walks through reconstitution, syringe units, storage, and how to read a Certificate of Analysis. Free, no account.
Read the guides